Cargando…
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?
OBJECTIVES: The German Pharmaceutical Market Restructuring Act (AMNOG, 2011) is a two-stage process to regulate the price of new pharmaceuticals in which price negotiations are conducted based on evidence-based medical benefit assessments using data from prior clinical trials. Although the act does...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227403/ https://www.ncbi.nlm.nih.gov/pubmed/37249741 http://dx.doi.org/10.1007/s40258-023-00815-7 |